GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
14 hedge funds and large institutions have $11.5K invested in GeneDx Holdings Warrant in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
8% more funds holding
Funds holding: 13 → 14 (+1)
56% less capital invested
Capital invested by funds: $26K → $11.5K (-$14.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$484 |
| 2 |
SG
StoneX Group
New York
|
+$428 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$10 |
| 4 |
CS
Clear Street
New York
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$6 |
WGSWW Hedge Fund Activity: Q2 2026 in Review
14 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2026, worth a combined $11.5K — down 56% from $26K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new WGSWW positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $484. The largest seller was Toronto Dominion Bank, cutting an estimated $6.
- 14 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2026, up from 13 in Q1 2026.
- Funds reported $11.5K of GeneDx Holdings Warrant stock for Q2 2026, down 56% quarter-over-quarter.
- 1 fund opened new GeneDx Holdings Warrant positions in Q2 2026 and 0 closed out, a net change of +1 holder.
- The largest GeneDx Holdings Warrant buyer in Q2 2026 was Virtu Financial, an estimated $484 added.
- The largest GeneDx Holdings Warrant seller in Q2 2026 was Toronto Dominion Bank, an estimated $6 sold.
Based on aggregated 13F filings for Q2 2026.